Your browser doesn't support javascript.
loading
Harnessing the immunotherapeutic potential of CDK4/6 inhibitors in melanoma: is timing everything?
Lelliott, Emily J; Sheppard, Karen E; McArthur, Grant A.
Afiliação
  • Lelliott EJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. emily.lelliott@petermac.org.
  • Sheppard KE; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia. emily.lelliott@petermac.org.
  • McArthur GA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
NPJ Precis Oncol ; 6(1): 26, 2022 Apr 20.
Article em En | MEDLINE | ID: mdl-35444175

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article